Coronavirus vaccines: five key questions as trials begin.

Callaway, Ewen

Callaway, Ewen.

Nature ; 579(7800): 481, 2020 03.

Article in English | MEDLINE | ID: covidwho-823253

Subject(s)

Biomedical Research; Coronavirus Infections/immunology; Coronavirus Infections/prevention & control; Disease Models, Animal; Immunologic Memory/immunology; Pandemics/prevention & control; Pneumonia, Viral/immunology; Pneumonia, Viral/prevention & control; Viral Vaccines/adverse effects; Viral Vaccines/immunology; Animals; COVID-19; COVID-19 Vaccines; Clinical Trials, Phase I as Topic; Guinea Pigs; Humans; Macaca mulatta/immunology; Macaca mulatta/virology; Mice; Risk Assessment; Spike Glycoprotein, Coronavirus/biosynthesis; Spike Glycoprotein, Coronavirus/genetics; Spike Glycoprotein, Coronavirus/immunology; T-Lymphocytes/immunology; Time Factors

Keywords

Infection; Virology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Biomedical Research / Disease Models, Animal / Pandemics / Immunologic Memory Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Animals / Humans Language: English Journal: Nature Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google